bst_global_new4_tm

Robert Cucin MD JD MBA August 28, 2017 0 Comment

Leave a Reply Cancel reply

You must be logged in to post a comment.

BioSculpture Tech. selected for Inclusion in the 2026 Yale Innovation Summit. May 6, 2026
The Company will appear in the Virtual Showcase to highlight our treatment innovations to 2,500+ attendees including investors, researchers, other founders, and potential partners through the Summit’s digital platform. The 2026 Innovation Summit is hosted by Yale University in New
Robert Cucin MD JD MBA
Food for Thought January 7, 2026
Why is it so hard to lose weight and keep it off? The GLP-1 agonists and new drugs under development with multiple actions can help. But for the vast majority of patients who can afford them and stay on them
Robert Cucin MD JD MBA
Why Visceral Fat is Bad December 21, 2025
The fat you can pinch may be unsightly, but it has little health consequence. It is that fat which you cannot see, deep inside your belly that causes all the morbidities of obesity – sleep apnea, GERD, type 2 diabetes,
Robert Cucin MD JD MBA
The War Against Obesity December 16, 2025
Despite the emergence of new pharmacologic alternatives to traditional bariatric surgery, the global obesity epidemic continues to escalate. Semaglutides, while effective for some, are costly, require weekly injections, and often cause side effects that lead many patients to discontinue treatment
Robert Cucin MD JD MBA
Obesity is Behind Nationwide Cancer Deaths July 17, 2025
An Endocrine Society article presented at ENDO 2025 reports that U.S. obesity-related deaths from 13 different cancers have tripled in the last two decades with women, older adults and minority groups most affected. The study examined more than 33,0000 deaths
Robert Cucin MD JD MBA
Nearly 2/3 of Patients Quit GLP-1 Drugs within the First Year February 4, 2025
In a recent study published in JAMA Network Open, 65% of those without diabetes discontinued their semaglutide drug in less than one year. The quit rates were not only for cost but for the side effects and complications. Those who
Robert Cucin MD JD MBA
208 Million Americans are Obese or Overweight November 28, 2024
In a study published in Lancet on November 14, 2024, conducted by the GBD 2021 Forecasting Collaborators using 132 data sources, nearly half of adolescents and three-quarters of adults in the U.S. were classified as being clinically overweight or obese.
Robert Cucin MD JD MBA
Weight Loss and Weight Loss Surgery Dramatically Reduces Cancer Risk June 15, 2022
Obesity increases the incidence and mortality from some types of cancer, but it remained uncertain whether intentional weight loss can decrease this risk. In a retrospective cohort study of 318 patients, bariatric surgery was significantly associated with a lower risk
Robert Cucin MD JD MBA
Cleveland Clinic Study Finds Weight Loss Surgery Decreases Risk of Heart Attack and Stroke September 8, 2019
Dr. Steven Nissen and colleagues compared the impact of various types of bariatric surgery on almost 2,300 people to the usual medical care on more than 11,000 obese patients with similar symptoms treated between 1998 and 2017 at the Cleveland
Robert Cucin MD JD MBA
Obesity Surgery Benefits May Be Greater For Teens Than Adults May 17, 2019
Most obese teens remain obese as adults, and adults who were obese as teens are unhealthier than those who become obese later in life. A new study presented at the Combating Childhood Obesity Conference in Houston (Weight Loss and Health
Robert Cucin MD JD MBA